Regenxbio Days Of Sales Outstanding from 2010 to 2024

RGNX Stock  USD 9.58  0.01  0.10%   
Regenxbio Days Of Sales Outstanding yearly trend continues to be fairly stable with very little volatility. Days Of Sales Outstanding will likely drop to 80.92 in 2024. During the period from 2010 to 2024, Regenxbio Days Of Sales Outstanding regression line of annual values had r-squared of  0.02 and arithmetic mean of  92.62. View All Fundamentals
 
Days Of Sales Outstanding  
First Reported
2010-12-31
Previous Quarter
106.54091221
Current Value
80.92
Quarterly Volatility
89.44961877
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Regenxbio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Regenxbio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 18.2 M, Interest Expense of 6.5 M or Selling General Administrative of 47.8 M, as well as many indicators such as Price To Sales Ratio of 8.26, Dividend Yield of 0.0 or PTB Ratio of 2.64. Regenxbio financial statements analysis is a perfect complement when working with Regenxbio Valuation or Volatility modules.
  
Check out the analysis of Regenxbio Correlation against competitors.
For more information on how to buy Regenxbio Stock please use our How to Invest in Regenxbio guide.

Latest Regenxbio's Days Of Sales Outstanding Growth Pattern

Below is the plot of the Days Of Sales Outstanding of Regenxbio over the last few years. It is Regenxbio's Days Of Sales Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Regenxbio's overall financial position and show how it may be relating to other accounts over time.
Days Of Sales Outstanding10 Years Trend
Pretty Stable
   Days Of Sales Outstanding   
       Timeline  

Regenxbio Days Of Sales Outstanding Regression Statistics

Arithmetic Mean92.62
Geometric Mean68.23
Coefficient Of Variation96.58
Mean Deviation47.36
Median80.92
Standard Deviation89.45
Sample Variance8,001
Range381
R-Value0.14
Mean Square Error8,436
R-Squared0.02
Significance0.61
Slope2.90
Total Sum of Squares112,017

Regenxbio Days Of Sales Outstanding History

2024 80.92
2023 106.54
2022 90.93
2021 25.17
2020 101.54
2019 395.2
2018 14.34

About Regenxbio Financial Statements

Regenxbio investors use historical fundamental indicators, such as Regenxbio's Days Of Sales Outstanding, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Regenxbio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Sales Outstanding 106.54  80.92 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Regenxbio Stock Analysis

When running Regenxbio's price analysis, check to measure Regenxbio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regenxbio is operating at the current time. Most of Regenxbio's value examination focuses on studying past and present price action to predict the probability of Regenxbio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regenxbio's price. Additionally, you may evaluate how the addition of Regenxbio to your portfolios can decrease your overall portfolio volatility.